Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
Revenue
€ 25.9 million
▲ 4% vs 2024
Profit
Growing€ 552,002
▲ 45% vs 2024
Debts
Low€ 7.4 million
▼ 33% vs 2024
NOBEL BIOCARE BELGIUM from Mechelen, company number BE0864916237, closed financial year 2025 with a result of € 552,002 after tax. For that financial year NOBEL BIOCARE BELGIUM recorded revenue of € 25.9 million and equity of € 6.6 million. Compared with financial year 2024, the result moved from € 381,160 to € 552,002. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
What happened at NOBEL BIOCARE BELGIUM?
What happened at NOBEL BIOCARE BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Patrick Perret stepped down as director. NBB
- Grégory Ben Fredj stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 552,002 (▲ 45% vs 2024). Source: NBB ↗
- Rudy Jacquemijn stepped down as director. NBB
- Patrick Perret became a director. NBB
- Grégory Ben Fredj became a director. NBB
- Rudy Jacquemijn became a director. NBB
- New establishment in Mechelen. KBO
In short
From € 282,858 profit in 2021 to € 552,002 profit in 2025.
Paid € 778,084 in corporate taxes since 2021.
Best year ever: 2025, with € 552,002 profit.
Pays suppliers within 92 days on average.
A new publication or filing at NOBEL BIOCARE BELGIUM? We notify you, reason included.
Follow NOBEL BIOCARE BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Grégory Ben Fredj
Gedeleerd bestuurder
since 2023 · until 2028
Rudy Jacquemijn
bestuurder
since 2013 · until 2025
Patrick Perret
bestuurder
since 2024 · until 2029
Establishments
Establishment units
Physical locations of this company
Stationsstraat 102-108
2800 Mechelen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
FASTLY - Fastly, Inc., US
Website info
Features
Security
Network
Details
- Company number
- 0864.916.237
- VAT number
- BE 0864.916.237
- Registered office
- Stationsstraat 102-108, 2800 Mechelen
- Names & denominations
- NOBEL BIOCARE BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 April 2004
- Peppol
- Active · Active since 29 Dec 2025
- Contact
- nobelbiocare.com
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden